Global Vaccine Adjuvants Competitive Landscape Professional Research Report 2024

Research Summary

Vaccine adjuvants are substances added to vaccines to enhance and improve the body's immune response to the antigen, which is the part of the vaccine that stimulates an immune reaction. Adjuvants play a crucial role in vaccines by amplifying the immune response, leading to increased antibody production and a more robust and long-lasting protection against the targeted pathogen. They work by triggering the innate immune system and promoting the activation of immune cells at the site of vaccination. Common adjuvants include aluminum salts, oil-in-water emulsions, and other immune-stimulating compounds. The use of adjuvants in vaccines allows for the development of effective vaccines with smaller amounts of antigen, reducing costs and improving vaccine efficacy. Vaccine adjuvants contribute significantly to the success of vaccination programs by enhancing the overall effectiveness of vaccines and promoting immunity against infectious diseases.

According to DIResearch's in-depth investigation and research, the global Vaccine Adjuvants market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Vaccine Adjuvants include GSK, CSL Limited, Croda, SEPPIC, Novavax, SPI Pharma, Phibro, SDA BIO, Invivogen, Tj Kaiwei, OZ Biosciences, Brenntag Biosector, MVP Laboratories, Zhuoyue, Aphios etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Vaccine Adjuvants. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Vaccine Adjuvants market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Vaccine Adjuvants market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Vaccine Adjuvants industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Vaccine Adjuvants Include:

GSK

CSL Limited

Croda

SEPPIC

Novavax

SPI Pharma

Phibro

SDA BIO

Invivogen

Tj Kaiwei

OZ Biosciences

Brenntag Biosector

MVP Laboratories

Zhuoyue

Aphios

Vaccine Adjuvants Product Segment Include:

Aluminum Adjuvant

Emulsions Adjuvant

Others

Vaccine Adjuvants Product Application Include:

Human Vaccine

Veterinary Vaccine

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Vaccine Adjuvants Industry PESTEL Analysis

Chapter 3: Global Vaccine Adjuvants Industry Porter's Five Forces Analysis

Chapter 4: Global Vaccine Adjuvants Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Vaccine Adjuvants Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Vaccine Adjuvants Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Vaccine Adjuvants Market Overview

1.1 Product Definition and Statistical Scope

1.2 Vaccine Adjuvants Product by Type

1.2.1 Global Vaccine Adjuvants Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Aluminum Adjuvant

1.2.3 Emulsions Adjuvant

1.2.4 Others

1.3 Vaccine Adjuvants Product by Application

1.3.1 Global Vaccine Adjuvants Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Human Vaccine

1.3.3 Veterinary Vaccine

1.4 Global Vaccine Adjuvants Market Revenue and Sales Analysis

1.4.1 Global Vaccine Adjuvants Market Size Analysis (2019-2030)

1.4.2 Global Vaccine Adjuvants Market Sales Analysis (2019-2030)

1.4.3 Global Vaccine Adjuvants Market Sales Price Trend Analysis (2019-2030)

1.5 Vaccine Adjuvants Market Development Status and Trends

1.5.1 Vaccine Adjuvants Industry Development Status Analysis

1.5.2 Vaccine Adjuvants Industry Development Trends Analysis

2 Vaccine Adjuvants Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Vaccine Adjuvants Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Vaccine Adjuvants Market Analysis by Regions

4.1 Vaccine Adjuvants Overall Market: 2023 VS 2024 VS 2030

4.2 Global Vaccine Adjuvants Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Vaccine Adjuvants Revenue and Market Share by Region (2019-2024)

4.2.2 Global Vaccine Adjuvants Revenue Forecast by Region (2025-2030)

4.3 Global Vaccine Adjuvants Sales and Forecast Analysis (2019-2030)

4.3.1 Global Vaccine Adjuvants Sales and Market Share by Region (2019-2024)

4.3.2 Global Vaccine Adjuvants Sales Forecast by Region (2025-2030)

4.4 Global Vaccine Adjuvants Sales Price Trend Analysis (2019-2030)

5 Global Vaccine Adjuvants Market Size by Type and Application

5.1 Global Vaccine Adjuvants Market Size by Type

5.1.1 Global Vaccine Adjuvants Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Vaccine Adjuvants Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Vaccine Adjuvants Market Size by Application

5.2.1 Global Vaccine Adjuvants Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Vaccine Adjuvants Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Vaccine Adjuvants Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Vaccine Adjuvants Market Size by Type

6.3.1 North America Vaccine Adjuvants Sales by Type (2019-2030)

6.3.2 North America Vaccine Adjuvants Revenue by Type (2019-2030)

6.4 North America Vaccine Adjuvants Market Size by Application

6.4.1 North America Vaccine Adjuvants Sales by Application (2019-2030)

6.4.2 North America Vaccine Adjuvants Revenue by Application (2019-2030)

6.5 North America Vaccine Adjuvants Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Vaccine Adjuvants Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Vaccine Adjuvants Market Size by Type

7.3.1 Europe Vaccine Adjuvants Sales by Type (2019-2030)

7.3.2 Europe Vaccine Adjuvants Revenue by Type (2019-2030)

7.4 Europe Vaccine Adjuvants Market Size by Application

7.4.1 Europe Vaccine Adjuvants Sales by Application (2019-2030)

7.4.2 ? Europe Vaccine Adjuvants Revenue by Application (2019-2030)

7.5 Europe Vaccine Adjuvants Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Vaccine Adjuvants Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Vaccine Adjuvants Market Size by Type

8.3.1 China Vaccine Adjuvants Sales by Type (2019-2030)

8.3.2 China Vaccine Adjuvants Revenue by Type (2019-2030)

8.4 China Vaccine Adjuvants Market Size by Application

8.4.1 China Vaccine Adjuvants Sales by Application (2019-2030)

8.4.2 China Vaccine Adjuvants Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Vaccine Adjuvants Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Vaccine Adjuvants Market Size by Type

9.3.1 APAC (excl. China) Vaccine Adjuvants Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Vaccine Adjuvants Revenue by Type (2019-2030)

9.4 APAC (excl. China) Vaccine Adjuvants Market Size by Application

9.4.1 APAC (excl. China) Vaccine Adjuvants Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Vaccine Adjuvants Revenue by Application (2019-2030)

9.5 APAC (excl. China) Vaccine Adjuvants Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Vaccine Adjuvants Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Vaccine Adjuvants Market Size by Type

10.3.1 Latin America Vaccine Adjuvants Sales by Type (2019-2030)

10.3.2 Latin America Vaccine Adjuvants Revenue by Type (2019-2030)

10.4 Latin America Vaccine Adjuvants Market Size by Application

10.4.1 Latin America Vaccine Adjuvants Sales by Application (2019-2030)

10.4.2 Latin America Vaccine Adjuvants Revenue by Application (2019-2030)

10.5 Latin America Vaccine Adjuvants Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Vaccine Adjuvants Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Vaccine Adjuvants Market Size by Type

11.3.1 Middle East & Africa Vaccine Adjuvants Sales by Type (2019-2030)

11.3.2 Middle East & Africa Vaccine Adjuvants Revenue by Type (2019-2030)

11.4 Middle East & Africa Vaccine Adjuvants Market Size by Application

11.4.1 Middle East & Africa Vaccine Adjuvants Sales by Application (2019-2030)

11.4.2 Middle East & Africa Vaccine Adjuvants Revenue by Application (2019-2030)

11.5 Middle East & Africa Vaccine Adjuvants Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Vaccine Adjuvants Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Vaccine Adjuvants Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Vaccine Adjuvants Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Vaccine Adjuvants Average Sales Price by Manufacturers (2020-2024)

12.2 Vaccine Adjuvants Competitive Landscape Analysis and Market Dynamic

12.2.1 Vaccine Adjuvants Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 GSK

13.1.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 GSK Vaccine Adjuvants Product Portfolio

13.1.3 GSK Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 CSL Limited

13.2.1 CSL Limited Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 CSL Limited Vaccine Adjuvants Product Portfolio

13.2.3 CSL Limited Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 Croda

13.3.1 Croda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Croda Vaccine Adjuvants Product Portfolio

13.3.3 Croda Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 SEPPIC

13.4.1 SEPPIC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 SEPPIC Vaccine Adjuvants Product Portfolio

13.4.3 SEPPIC Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 Novavax

13.5.1 Novavax Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Novavax Vaccine Adjuvants Product Portfolio

13.5.3 Novavax Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 SPI Pharma

13.6.1 SPI Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 SPI Pharma Vaccine Adjuvants Product Portfolio

13.6.3 SPI Pharma Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.7 Phibro

13.7.1 Phibro Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Phibro Vaccine Adjuvants Product Portfolio

13.7.3 Phibro Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.8 SDA BIO

13.8.1 SDA BIO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 SDA BIO Vaccine Adjuvants Product Portfolio

13.8.3 SDA BIO Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.9 Invivogen

13.9.1 Invivogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Invivogen Vaccine Adjuvants Product Portfolio

13.9.3 Invivogen Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.10 Tj Kaiwei

13.10.1 Tj Kaiwei Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Tj Kaiwei Vaccine Adjuvants Product Portfolio

13.10.3 Tj Kaiwei Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.11 OZ Biosciences

13.11.1 OZ Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 OZ Biosciences Vaccine Adjuvants Product Portfolio

13.11.3 OZ Biosciences Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.12 Brenntag Biosector

13.12.1 Brenntag Biosector Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Brenntag Biosector Vaccine Adjuvants Product Portfolio

13.12.3 Brenntag Biosector Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.13 MVP Laboratories

13.13.1 MVP Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 MVP Laboratories Vaccine Adjuvants Product Portfolio

13.13.3 MVP Laboratories Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.14 Zhuoyue

13.14.1 Zhuoyue Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Zhuoyue Vaccine Adjuvants Product Portfolio

13.14.3 Zhuoyue Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.15 Aphios

13.15.1 Aphios Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Aphios Vaccine Adjuvants Product Portfolio

13.15.3 Aphios Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Vaccine Adjuvants Industry Chain Analysis

14.2 Vaccine Adjuvants Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Vaccine Adjuvants Typical Downstream Customers

14.4 Vaccine Adjuvants Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support